The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, ...

DHAKA, April 29, 2025 (BSS) - A recent report by the online news portal BD Digest claiming that Bangladesh has lost control ...

The continued solid uptake of BD's products is expected to have driven fiscal second-quarter revenues despite transitory ...

Becton, Dickinson and Company has struggled over the past decade, with a 10-year CAGR of only 5.1%. Read what keeps me on the ...

Shares of Becton Dickinson & Co. BDX advanced 1.05% to $204.45 Thursday, on what proved to be an all-around positive trading ...

BD has received 510(k) clearance from the FDA for the Phasix ST Umbilical Hernia Patch, enabling the launch of the product ...

Government contractors lose billions annually on contracts they should have won due to one simple, fixable mistake, writes BD ...

Shares of Becton Dickinson & Co. BDX rose 1.22% to $202.32 Wednesday, on what proved to be an all-around favorable trading ...

Piper Sandler analyst Jason Bednar lowered the firm’s price target on Becton Dickinson to $260 from $280 and keeps an Overweight rating on the ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $260.00.

The FDA has issued a safety warning regarding a potentially high-risk issue involving certain BD PowerPICC Intravascular Catheters. The affected devices are 4 Fr. Single Lumen PowerPICC catheters, ...